161 related articles for article (PubMed ID: 35447688)
21. Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE Bioreactor™-part II: Applications for antibody production and cryopreservation.
Clincke MF; Mölleryd C; Samani PK; Lindskog E; Fäldt E; Walsh K; Chotteau V
Biotechnol Prog; 2013; 29(3):768-77. PubMed ID: 23436783
[TBL] [Abstract][Full Text] [Related]
22. Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion Mode.
Bürgin T; Coronel J; Hagens G; Keebler MV; Genzel Y; Reichl U; Anderlei T
Methods Mol Biol; 2020; 2095():105-123. PubMed ID: 31858465
[TBL] [Abstract][Full Text] [Related]
23. Monitoring online biomass with a capacitance sensor during scale-up of industrially relevant CHO cell culture fed-batch processes in single-use bioreactors.
Metze S; Ruhl S; Greller G; Grimm C; Scholz J
Bioprocess Biosyst Eng; 2020 Feb; 43(2):193-205. PubMed ID: 31549309
[TBL] [Abstract][Full Text] [Related]
24. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development.
Lu F; Toh PC; Burnett I; Li F; Hudson T; Amanullah A; Li J
Biotechnol Bioeng; 2013 Jan; 110(1):191-205. PubMed ID: 22767053
[TBL] [Abstract][Full Text] [Related]
25. Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies.
Liang K; Luo H; Li Q
Front Bioeng Biotechnol; 2023; 11():1112349. PubMed ID: 36741761
[TBL] [Abstract][Full Text] [Related]
26. Engineering death resistance in CHO cells for improved perfusion culture.
MacDonald MA; Nöbel M; Martínez VS; Baker K; Shave E; Gray PP; Mahler S; Munro T; Nielsen LK; Marcellin E
MAbs; 2022; 14(1):2083465. PubMed ID: 35737825
[TBL] [Abstract][Full Text] [Related]
27. Effects of pyruvate on primary metabolism and product quality for a high-density perfusion process.
Caso S; Aeby M; Jordan M; Guillot R; Bielser JM
Biotechnol Bioeng; 2022 Apr; 119(4):1053-1061. PubMed ID: 35023143
[TBL] [Abstract][Full Text] [Related]
28. A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.
Janoschek S; Schulze M; Zijlstra G; Greller G; Matuszczyk J
Biotechnol Prog; 2019 Mar; 35(2):e2757. PubMed ID: 30479066
[TBL] [Abstract][Full Text] [Related]
29. Shift to high-intensity, low-volume perfusion cell culture enabling a continuous, integrated bioprocess.
Gagnon M; Nagre S; Wang W; Hiller GW
Biotechnol Prog; 2018 Nov; 34(6):1472-1481. PubMed ID: 30298995
[TBL] [Abstract][Full Text] [Related]
30. Improving culture performance and antibody production in CHO cell culture processes by reducing the Warburg effect.
Buchsteiner M; Quek LE; Gray P; Nielsen LK
Biotechnol Bioeng; 2018 Sep; 115(9):2315-2327. PubMed ID: 29704441
[TBL] [Abstract][Full Text] [Related]
31. Soft-sensors application for automated feeding control in high-throughput mammalian cell cultures.
Martínez-Monge I; Martínez C; Decker M; Udugama IA; Marín de Mas I; Gernaey KV; Nielsen LK
Biotechnol Bioeng; 2022 Apr; 119(4):1077-1090. PubMed ID: 35005786
[TBL] [Abstract][Full Text] [Related]
32. Optimization and control of perfusion cultures using a viable cell probe and cell specific perfusion rates.
Dowd JE; Jubb A; Kwok KE; Piret JM
Cytotechnology; 2003 May; 42(1):35-45. PubMed ID: 19002926
[TBL] [Abstract][Full Text] [Related]
33. Process Analytical Technology for Advanced Process Control in Biologics Manufacturing with the Aid of Macroscopic Kinetic Modeling.
Kornecki M; Strube J
Bioengineering (Basel); 2018 Mar; 5(1):. PubMed ID: 29547557
[TBL] [Abstract][Full Text] [Related]
34. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
[TBL] [Abstract][Full Text] [Related]
35. Development of a shake tube-based scale-down model for perfusion cultures.
Wolf MKF; Lorenz V; Karst DJ; Souquet J; Broly H; Morbidelli M
Biotechnol Bioeng; 2018 Nov; 115(11):2703-2713. PubMed ID: 30039852
[TBL] [Abstract][Full Text] [Related]
36. Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.
Fernandes B; Correia R; Alves PM; Roldão A
Front Bioeng Biotechnol; 2022; 10():917746. PubMed ID: 35845394
[TBL] [Abstract][Full Text] [Related]
37. Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.
Combs RG; Yu E; Roe S; Piatchek MB; Jones HL; Mott J; Kennard ML; Goosney DL; Monteith D
Biotechnol Prog; 2011; 27(1):201-8. PubMed ID: 21312367
[TBL] [Abstract][Full Text] [Related]
38. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
39. Chemometrics and in-line near infrared spectroscopic monitoring of a biopharmaceutical Chinese hamster ovary cell culture: prediction of multiple cultivation variables.
Clavaud M; Roggo Y; Von Daeniken R; Liebler A; Schwabe JO
Talanta; 2013 Jul; 111():28-38. PubMed ID: 23622522
[TBL] [Abstract][Full Text] [Related]
40. Using Metabolomics to Identify Cell Line-Independent Indicators of Growth Inhibition for Chinese Hamster Ovary Cell-based Bioprocesses.
Alden N; Raju R; McElearney K; Lambropoulos J; Kshirsagar R; Gilbert A; Lee K
Metabolites; 2020 May; 10(5):. PubMed ID: 32429145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
